Publications by authors named "Bruce Acres"

Claim this Profile
T
Targeted Immunotherapy Designed to Treat MUC1-Expressing Solid Tumour.
Bruce Acres, Gisele Lacoste, Jean-Marc Limacher

Curr Top Microbiol Immunol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TG1042 (Adenovirus-interferon-γ) in primary cutaneous B-cell lymphomas: a phase II clinical trial.
Brigitte Dreno, Mirjana Urosevic-Maiwald, Youn Kim, Joan Guitart, Madeleine Duvic, Bruce Acres

PLoS One· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial.
Elisabeth Quoix, Rodryg Ramlau, Virginie Westeel, Zsolt Papai, Anne Madroszyk, Bruce Acres

Lancet Oncol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings.
Stéphane Oudard, Olivier Rixe, Benoit Beuselinck, Claude Linassier, Eugeniu Banu, Bruce Acres

Cancer Immunol Immunother· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic vaccinia virus: a silver bullet?
Monika Lusky, Philippe Erbs, Johann Foloppe, R Bruce Acres

Expert Rev Vaccines· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II clinical trial of intratumoral application of TG1042 (adenovirus-interferon-gamma) in patients with advanced cutaneous T-cell lymphomas and multilesional cutaneous B-cell lymphomas.
Reinhard Dummer, Stefan Eichmüller, Sylke Gellrich, Chalid Assaf, Brigitte Dreno, Bruce Acres

Mol Ther· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical development of MVA-based therapeutic cancer vaccines.
Bruce Acres, Jean-Yves Bonnefoy

Expert Rev Vaccines· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of Tg4010 (Mva-Muc1-Il2) in association with chemotherapy in patients with stage III/IV Non-small cell lung cancer.
Rodryg Ramlau, Elisabeth Quoix, Janusz Rolski, Miklos Pless, Herve Lena, Bruce Acres

J Thorac Oncol· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intralesional adenovirus-mediated interleukin-2 gene transfer for advanced solid cancers and melanoma.
Reinhard Dummer, Christoph Rochlitz, Thierry Velu, Bruce Acres, Jean-Marc Limacher

Mol Ther· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specific tumor cell targeting by a recombinant MVA expressing a functional single chain antibody on the surface of intracellular mature virus (IMV) particles.
Stéphane Paul, Michel Geist, Karine Dott, David Snary, Joyce Taylor-Papadimitriou, Bruce Acres

Viral Immunol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type I IFN innate immune response to adenovirus-mediated IFN-gamma gene transfer contributes to the regression of cutaneous lymphomas.
Mirjana Urosevic, Kazuyasu Fujii, Bastien Calmels, Elisabeth Laine, Nikita Kobert, Bruce Acres

J Clin Invest· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer immunotherapy: phase II clinical studies with TG4010 (MVA-MUC1-IL2).
Bruce Acres

J BUON· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer vaccines: challenges and outlook in the field.
Stéphane Paul, Bruce Acres, Jean-Marc Limacher, Jean-Yves Bonnefoy

IDrugs· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[MUC1, a therapeutic target in oncology].
Jean-Marc Limacher, Bruce Acres

Bull Cancer· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and development of therapeutic cancer vaccines.
Bruce Acres, Jean-Marc Limacher, Jeanoy Bonnefoy

Curr Opin Drug Discov Devel· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fusokine interleukin-2/interleukin-18, a novel potent innate and adaptive immune stimulator with decreased toxicity.
Bruce Acres, Murielle Gantzer, Christelle Remy, Nicolas Futin, Nathalie Accart

Cancer Res· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MUC1 as a target antigen for cancer immunotherapy.
Bruce Acres, Jean-Marc Limacher

Expert Rev Vaccines· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secretomers as a new tool for the monitoring of CTL responses.
Bastien Calmels, Stephane Paul, Christelle Ziller, Bruce Acres

Cancer Immunol Immunother· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bypassing tumor-associated immune suppression with recombinant adenovirus constructs expressing membrane bound or secreted GITR-L.
Bastien Calmels, Stéphane Paul, Nicolas Futin, Catherine Ledoux, Fabienne Stoeckel, Bruce Acres

Cancer Gene Ther· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene-based cancer immunotherapy and vaccines.
Bruce Acres, Patrick Squiban, Margaret Liu

Discov Med· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of antigen-specific gene therapy using a recombinant vaccinia virus encoding MUC-1 and IL-2 in MUC-1-positive patients with advanced prostate cancer.
Allan J Pantuck, Arndt van Ophoven, Barbara J Gitlitz, Cho-Lea Tso, Bruce Acres

J Immunother· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene-based vaccines and immunotherapeutics.
Margaret Liu, Bruce Acres, Jean-Marc Balloul, Nadine Bizouarne, Stephane Paul

Proc Natl Acad Sci U S A· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adenovirus-mediated intralesional interferon-gamma gene transfer induces tumor regressions in cutaneous lymphomas.
Reinhard Dummer, Jessica C Hassel, Friederike Fellenberg, Stefan Eichmüller, Tanja Maier, Bruce Acres

Blood· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic cancer vaccines.
Bruce Acres, Stephane Paul, Helene Haegel-Kronenberger, Bastien Calmels, Patrick Squiban

Curr Opin Mol Ther· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic Breast Tumour Regression Following Treatment by a Gene-Modified Vaccinia Virus Expressing MUC1 and IL-2.
Susy Scholl, Patrick Squiban, Nadine Bizouarne, Martine Baudin, Bruce Acres

J Biomed Biotechnol· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis